IR and lower sex hormone-binding globulin than non-Hispanic White girls (p < 0.01). Conclusions: In nonobese girls of diverse racial and ethnic backgrounds, WC, particularly when adjusted for race or ethnicity, is an independent predictor of IR comparable to MRI-derived measurements of fat and superior to the BMI Z-score.
Introduction
Comorbidity rates related to obesity, most notably type 2 diabetes mellitus (T2DM), have increased in parallel to rises in pediatric obesity during the past decades and are incurring profound health and economic burdens. In the US, approximately 3,700 youths are diagnosed with T2DM annually [1] . Importantly, youths with T2DM exhibit a more rapid deterioration of β-cell function than older adults and often develop significant cardiovascular morbidity and mortality in the 3rd decade of life [2, 3] . These findings highlight the need for reliable and costeffective methods to identify youths at the greatest risk for metabolic consequences of obesity. Currently, there is a lack of consensus whether body mass index (BMI), waist circumference (WC), or another anthropometric mea-sure provides a superior screening approach [4, 5] . The development of a consensus is complicated by evidence that the metabolic effects exerted by a given amount of fat vary with race and ethnicity [6, 7] and that WC and BMI fail to directly quantify site-specific fat deposition.
While WC and BMI are easily obtained estimates of adiposity, magnetic resonance imaging (MRI) can evaluate and quantify fat deposition with high accuracy and at specific anatomic sites. In obese adolescents, MRI demonstrates higher levels of visceral adipose tissue (VAT) and hepatic fat in subjects of Hispanic and European descent compared to those of African descent despite similar overall body fat percentage [8, 9] . These imaging results suggest that racial and ethnic patterns of fat deposition may contribute to racial and ethnic disparities in the rates and pathophysiology of T2DM and other metabolic diseases [10] . Importantly, these racial or ethnic tendencies for deleterious fat deposition can be detected at lower levels of accrued fat [11] . For example, nonobese Hispanic adolescent girls exhibit higher levels of hepatic fat measured by MRI, with tighter correlations between insulin resistance (IR) and hepatic fat, than nonobese, nonHispanic White peers [7] .
With its ability to accurately and rapidly quantify fat without the use of ionizing radiation, MRI holds promise for accurately defining pathologic connections between compartmentalization of fat deposition and metabolic health. However, MRI currently remains an impractical clinical screening tool. Instead, prevention and early intervention strategies are better served by clinically available measures that can identify those at risk for adverse metabolic effects of excess fat who should receive further laboratory or imaging evaluations. This study, innovative in its focus on nonobese girls of African-American, Hispanic, and non-Hispanic White ancestry, investigates whether anthropometric measures (i.e. WC and BMI Zscore) provide a metabolic risk assessment comparable in value to MRI-derived measurements of fat deposition [VAT, subcutaneous adipose tissue (SCAT), and hepatic proton density fat fraction (PDFF)].
Methods

Study Population
Nonobese female students who attended a local middle-school fall registration were invited to participate in this cross-sectional study. Once written consent and assent were obtained for the HIPAA-compliant and Institutional Review Board-approved study, personal and family medical history and self-identified race and ethnicity (per NIH race and ethnicity criteria for subjects in clinical research) were collected at registration. Individuals of Asian descent were not included. Height was measured using a stadiometer and recorded to the nearest 0.5 cm. WC was measured twice and recorded to the nearest 1 mm just above the iliac crests with a Graham-Field ® cloth-woven measuring tape. Weight was measured without shoes in light clothes on a beam balance platform scale to the nearest 0.1 kg. BMI was then calculated. Selfassessment of Tanner staging for breast and pubic hair was performed [12] .
Study entrance criteria included a nonobese BMI <90th percentile per Centers for Disease Control (CDC) 2000 sex-and agespecific BMI growth charts and an age of 11-14 years. Based on family self-identification, subjects were allocated to Hispanic White, non-Hispanic White, or African-American groups. To ensure recruitment of a nonobese study group, we set the upper limit for BMI at the 90th percentile, rather than at the 95th percentile. Exclusion criteria included a BMI >90th percentile for age and gender, type 1 or 2 diabetes mellitus, chronic diseases (including infectious or inflammatory diseases), treatment with glucose metabolism-altering (e.g. metformin) or lipid-altering (e.g. statin) agents, or pregnancy. 
Laboratory
Image Acquisition and Reconstruction
Volumetric 3D quantitative MRI was performed using a clinical 3-tesla scanner (MR750, GE Healthcare, Waukesha, Wis., USA) and a 32-channel phased array body coil (Neocoil, Pewaukee, Wis., USA), and all image acquisition and reconstruction was performed using established and accepted protocols [13] [14] [15] [16] [17] [18] [19] [20] [21] . All images were determined using an investigational version of a confounder-corrected chemical shift-encoded water-fat separation method (3D-IDEAL-SPGR) [13, 22] . Two acquisitions were performed, including a sagittal 3D volume that covered the liver dome to the pelvic floor (to quantify VAT and SCAT) and an axial 3D volume covering the liver to quantify hepatic PDFF. Acquisition parameters for the sagittal acquisition included: a single sagittal slab with 6 echoes, first echo time/echo spacing = 0.8/1.2 ms; echo [23] were calculated using an automated on-line reconstruction algorithm. The acquisition and reconstruction are designed to avoid or correct for all known confounders, including spectral modeling of fat [24] , and to correct for eddy currents [15] , T1 bias [25] , T2 * decay [16] , and noiserelated bias [25] . Because all known confounders have been addressed, the resulting PDFF map provides an accurate and fundamental measure of the fat concentration in tissue [13, 26] .
Hepatic PDFF was determined by averaging the PDFF value measured from 9 regions of interest placed in each of the 9 Couinaud segments of the liver [22, 27] . Hepatic steatosis was defined as PDFF >5.56% [19] .
Manual VAT and SCAT quantification was performed from the L3 to L5 vertebral levels. Segmentation was performed in SliceOmatic version 5.0 as follows. Intestinal gas and bowel contents as well as background voxels were masked prior to application of a 45% threshold on the fat fraction images [20] . Fat signals near the spine and bone marrow were manually erased.
Statistics
Metabolic laboratory parameters and subjects' characteristics measured on a continuous scale are presented as means ± standard deviations (SD) and were compared for race and ethnic groups using analysis of variance. Nonparametric Spearman's rank correlation analysis was performed to evaluate bivariate associations between variables. Categorical variables were compared between groups using Fisher's exact test. Tukey's honestly significant difference (HSD) method was used to control the type 1 error when conducting multiple comparisons between the three groups. Multivariate analyses were conducted to examine whether BMI Zscore, WC, hepatic PDFF, SCAT, and VAT measures predict IR, after adjusting for race and ethnicity. These analyses were conducted separately for each measure. Furthermore, multivariate regression analyses were conducted to identify independent predictors of IR. All potential predictors were included in an initial, nonparsimonious model. The backward and forward selection methods with a selection criterion of p < 0.1 were then used to determine a parsimonious model which included only significant predictors. The identification of independent predictors was validated using the least absolute shrinkage and selection operator (LASSO) variable selection method. Fasting insulin concentration and HOMA-IR values were log transformed in the regression analyses to meet the assumption of normality. Statistical inference was performed with the maximum likelihood estimation. All statistical analyses were performed with SAS software (version 8.2; SAS Institute, Cary, N.C., USA). All p values were 2-sided, and p values ≤ 0.05 were considered statistically significant.
Results
A summary of the characteristics of the 57 subjects (12 African-American, 16 Hispanic, and 29 non-Hispanic White) is presented in table 1 . There were no statistically significant differences in mean age, BMI Z-score, WC, estradiol levels, or occurrence of menarche between the racial and ethnic groups when adjusting for multiple comparisons. For the unadjusted comparisons, significant differences were detected when comparing WC between Hispanics and non-Hispanics (p = 0.029) and between African-Americans and non-Hispanics for LH (p = 0.038). The significant difference in LH may have been attributable to the presence of an outlier in the African-American group. With removal of the subject with an LH of 103.5 mIU/ml, the difference was nonsignificant. Using the Values are means ± SD unless otherwise specified. There were no significant racial or ethnic differences between the groups in the variables above, with all p > 0.05 when comparisons of ethnic and racial group means were adjusted for multiple comparisons using Tukey's HSD method. 261 CDC 2000 sex-and age-specific BMI growth chart, the mean BMI Z-scores were consistent with mean BMI percentiles at the 63rd percentile in African-American subjects, at the 64th percentile in Hispanic subjects, and at the 58th percentile in non-Hispanic White subjects.
Waist Circumference Predicts Insulin Resistance
A comparison of the metabolic laboratory parameters by race and ethnicity indicated that the Hispanic subjects had significantly higher mean fasting insulin (23.3 ± 11.9 vs. 12.6 ± 6.14 μIU/ml; p = 0.002), higher mean HOMA-IR (5.18 ± 3.20 vs. 2.76 ± 1.42; p = 0.006), and lower mean SHBG (44.0 ± 24.1 vs. 72.3 ± 28.6 nmol/l; p = 0.004) than non-Hispanic White subjects when adjusted for multiple comparisons ( table 2 ). As shown in table 2 , there were no statistically significant differences detected between the Hispanic and non-Hispanic White groups for any of the 4 other metabolic parameters (adiponectin, leptin, HDL, and triglycerides), and there were no statistically significant differences between the African-American and Hispanic groups or between the African-American and nonHispanic White groups for any of the 7 metabolic parameters (fasting insulin, HOMA-IR, SHBG, adiponectin, leptin, HDL, and triglycerides) when adjusted for multiple comparisons ( table 2 ) .
Overall, moderate-to-strong correlations of WC with metabolic parameters (fasting insulin, HOMA-IR, triglycerides, SHBG, adiponectin, and leptin) were observed, similar to those seen with VAT and SCAT ( table 3 ). BMI Z-score correlations with metabolic parameters were only significant for fasting insulin, HOMA-IR, SHBG, adiponectin, and leptin ( table 3 ) . WC correlated more strongly with all of these metabolic parameters than BMI Z-score; however, the difference in r-values did not reach statistical significance. Figure 1 illustrates the correlations of WC and BMI Z-score with HOMA-IR.
In multivariate analyses, WC, BMI Z-score, hepatic PDFF, VAT, and SCAT remained statistically significant predictors of fasting insulin and HOMA-IR after adjusting for race and ethnicity. The partial Spearman rank correlations for predicting fasting insulin levels increased substantially for SCAT and VAT from 0.34 and 0.29 to 0.63 and 0.69, respectively, after adjusting for race and ethnicity. Values are means ± SD. * There was a significant difference (p < 0.01) in mean fasting insulin, HOMA-IR, and SHBG between Hispanic and non-Hispanic White groups; otherwise, there were no significant differences between racial and ethnic group means, with all p > 0.05 when adjusted for multiple comparisons using Tukey's HSD method. In order to identify independent predictors of fasting insulin and HOMA-IR, multivariate regression analyses were conducted. In the initial nonparsimonious model, WC, BMI Z-score, hepatic PDFF, SCAT, VAT, age, and race and ethnicity were included as independent variables in the model. The backward and forward selection method was used to identify parsimonious models (see Methods). In the parsimonious model, WC (p = 0.012), VAT (p = 0.0031), and race and ethnicity (African-American vs. non-Hispanic White, p = 0.0092; Hispanic vs. nonHispanic White, p = 0.022) were identified as statistically significant independent predictors of fasting insulin ( table 4 ). The adjusted R 2 value for this model was 0.54. Analogously, WC (p = 0.013), VAT (p = 0.0024), and ethnicity (Hispanic vs. non-Hispanic White, p = 0.0049) were identified as statistically significant predictors of HOMA-IR with an adjusted R 2 value of 0.53 ( table 4 ) .
There was no statistically significant difference in the slope of the correlation between WC and VAT (p = 0.15 for fasting insulin and p = 0.16 for HOMA-IR). These results were confirmed using the LASSO variable selection method.
Discussion
In this group of nonobese young females of AfricanAmerican, Hispanic White, and non-Hispanic White background, WC independently predicted IR to a degree comparable to (i.e. not significantly different from) that of MRI-derived VAT and stronger than the BMI Z-score. While WC has been previously shown to correlate with MRI-measured VAT in both obese and nonobese youths [28] , this study adds the novel observation that, at non- obese levels of adiposity defined by BMI percentile, WC predicts HOMA-IR and fasting insulin better than the BMI Z-score and to a similar degree as MRI-derived measures of fat (hepatic PDFF, VAT, and SCAT). These results suggest that, in nonobese girls, use of WC alone can improve pediatric risk stratification for IR risk over the current BMI-based approach. Evidence from other studies suggests that inclusion of both WC-and BMI-based measurements improves pediatric risk stratification into general categories of 'healthy' and 'unhealthy' obesity [5, 29, 30] . A key finding of this study is the additional utility of WC in identifying nonobese (by BMI criteria) subjects who are already experiencing adverse health consequences from adiposity. Therefore, a greater reliance on the assessment of WC, easily obtained in clinical practice, could provide valuable information about a child's fat distribution and risk for IR. The increasing use of electronic medical records may facilitate the incorporation of WC and other anthropometric measures into clinically useful predictive equations [31] .
Importantly, the predictive value of WC for fasting insulin and HOMA-IR was increased by racial and ethnic adjustments in the nonobese girls. While admittedly based on relatively few subjects, this finding suggests that adjustment of BMI and/or WC thresholds that would trigger concern for underlying IR based on an individual's race or ethnicity may be appropriate, since it appears that certain ethnic or racial groups manifest adverse health effects at lower degrees of fat deposition [32, 33] . In the US, WC percentile curves based on NHANES data for African-American and Mexican-American youths have greater absolute raw WCs than those for White children; thus, a larger percentage of non-White children may be identified as at high risk using WC criteria compared to BMI alone [34] .
The WC-to-height ratio has been proposed as an informative marker of abdominal obesity and metabolic risk because, relative to WC or BMI, it is more independent of patient age, pubertal status, and gender [35] . Further, a WC-to-height ratio of >0.5 was proposed to define central obesity for all races and ethnicities instead of the use of various BMI or WC thresholds to assess habitus and metabolic risk -a threshold that additionally provides patients with a simple message to keep their WC less than 1/2 their height [36] . However, the use of the WCto-height ratio, rather than WC, did not improve the prediction of IR in our nonobese adolescent cohort (data not shown), and further study is needed in pediatric patients.
A fundamental issue is determining the best anatomic cross-section to measure WC. Interestingly, in youths, WC measurement at 4 different abdominal cross-sections (midpoint between iliac crest and lowest rib, top of the iliac crest, minimal abdominal circumference, and level of the umbilicus) does not affect WC correlations with VAT or fasting glucose and lipids [37] . However, a standardized approach to WC measurements would minimize variability, improve reproducibility, and thereby increase its clinical and research utility [38] . This study, following the technique utilized for the generation of the previously mentioned NHANES database, used the top of the iliac crests as markers, which provide bilateral bony landmarks to minimize variability of WC measurement.
This study has potential limitations, beginning with the categorization of subjects into broad racial and ethnic groups (which include genetic and cultural heterogeneity among subjects) and inclusion of children with one or more parents with African or Hispanic ancestry into the African-American or Hispanic cohort, respectively. The enrollment for the subgroup analysis was relatively small, so that observations describing differences based on race and ethnicity are preliminary and require confirmation by studies of greater numbers of subjects. In addition, whether the findings described here are applicable to male subjects and adolescents of other races and ethnicities remains uncertain. Further, future inclusion of subjects with BMI percentiles above the 90th percentile would be expected to allow an increase in the level and variability of IR and allow an analysis of how evolving obesity affects the prediction of IR by BMI-, WC-, and MRI-based measures. In addition, although efforts were made to document similar pubertal maturation between groups (based on self-assessment and estradiol levels), variations in pubertal status could remain a potential confounding factor, given important effects of puberty on IR [39] . Additionally, although a verification of Tanner staging by a medical provider would have confirmed the staging assessment, formal evaluation was not performed given the potential for reduced enrollment that a mandatory physical examination would have created. Further, while fasting indices used in this study correlate closely with oral glucose tolerance testing in assessing IR in obese adolescents [40] , oral glucose tolerance testing may yield IR assessments more closely aligned with gold-standard hyperinsulinemic-euglycemic clamp testing. Strengths of this study include the analysis of children of different races and ethnicities and the use of advanced quantitative MRI methods to quantify fat deposition and correlate them with standard laboratory markers of IR. An additional strength was the unique focus on nonobese subjects from diverse racial and ethnic backgrounds (mean BMI Z-scores at the 63rd, 64th, and 58th percentiles for the African-American, Hispanic, and non-Hispanic White groups, respectively).
Conclusion
WC measurement is an informative and inexpensive risk stratification tool for IR in children, even before progression of adiposity to obesity, as defined by BMI percentile. Specifically, in a cohort of nonobese girls, WC predicted IR better than the BMI Z-score and to a similar extent as quantitative MRI measurements of fat. Additionally, WC and MRI VAT independently predicted IR, and this prediction was further strengthened when racial and ethnic background was taken into account. The fact that these findings were evident in a cohort of nonobese adolescent girls strengthens the concept that adverse metabolic changes can occur early in the course of fat deposition, making early detection and promotion of healthy physical activity and nutrition of at-risk but still nonobese children paramount, particularly since the obesity prevalence rises sharply during early-grade school [41] .
